TrialJectory
Robert E. Winkler, M.D. is an advisor at TrialJectory. Robert has also worked as the head of clinical development and operations at Aptalis, Amicus Therapeutics, and Novartis Oncology. Robert has also served on the board of advisors for Profounda, Inc. Dr. Winkler received their medical degree from the University of California, San Francisco.
Dr. Robert E. Winkler is a medical doctor who received their MD from The Hebrew University of Jerusalem. Robert also has a degree in executive education from Rutgers Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
TrialJectory
1 followers
TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. We use artificial intelligence (AI) to empower patients to own their cancer journey and analyze our global patient community's real-world data to empower cancer patients to make the most informed decisions about their care.